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ABSTRACT
Aims: To generate new medicaments for control and treatment of the parasitic protozoan
Toxoplasma gondii.
Study Design: Structure similarity search and isostere search was conducted over a broad range
of structure categories. Correlation and highest similarity scores were implemented to select the
best drug candidates.
Place and Duration of Study: University of Nebraska, Department of Chemistry, Durham Science
Center, 6001 Dodge Street, Omaha Nebraska 68182, from June 2016 to February 2017.
Methodology: Utilizing pyrimethamine as the parent compound, a broad range of similar structures
and isosteres were found by applying search methods. The compounds having the highest
correlation and similarity scores were selected for the study of molecular properties. The molecular
properties were determined and examined for underlying relationships by pattern recognition
hierarchical cluster analysis and K-means cluster analysis.
Results: Thirty compounds were identified to have a very high level of structure similarity or
isosteric relationship to pyrimethamine. The molecular structures and molecular properties are
_____________________________________________________________________________________________________
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presented for all compounds, inclusive of pyrimethamine. Hierarchical cluster analysis and K-means
cluster analysis indicated compounds with highest underlying similarity to pyrimethamine. Box plots
showed the over-all distribution of important pharmaceutical properties, such as molecular weight,
Log P, polar surface area, number of rotatable bonds, molecular volume, and number of hydrogen
bond donors. Structure components are compared to elucidate potential clinical activity. Multiple
regression is applied on all compounds to generate a numerical relationship for prediction of similar
compounds. Save for only one isostere, all compounds showed zero violations of the Rule of 5,
indicating favorable drug-likeness and bioavailability.
Conclusion: Thirty compounds highly analogous to pyrimethamine were identified following
heuristic search course. The molecular properties were determined for all compounds and indicated
genuine potential for treatment of toxoplasmosis. Correlation of structure and pattern recognition
methods indicated 30 compounds of clinical potential and property analogy to pyrimethamine.

Keywords: Protozoan; Toxoplasma gondii; pyrimethamine; antimalarial; isosteres.

ABBREVIATIONS
PSA: Polar surface area; MW: Molecular weight; nOHNH: Number of hydroxyl and amine groups;
nON: Number of oxygen and nitrogen atoms.
Antiprotozoal agents (ATC code: ATC PO1) are
grouped together as medicinal applied in the
clinical treatment of protozoan infection [8]. This
group of medicinal agents are distinguish by their
mechanism of action or by organism type, they
include the following [8,9,10]: eflornithine,
furazolidone,
metronidazole,
ornidazole,
pentamidine, pyrimethamine, and tinidazole.
Pyrimethamine (5-(4-chlorophenyl)-6-ethyl-2,4pyrimidinediamine)
is
well
absorbed,
administered orally, has a high protein binding
capacity, and is excreted by the kidneys [11].
There
is
widespread
resistance
to
pyrimethamine, and the side effects include
nausea, vomiting, headache, and diarrhea [7].
Despite this, pyrimethamine is considered among
the most important medications for basic health
maintenance. This due to a large part to the
serious socio-economic and health burden of
Toxoplasma gondii proliferation in developed and
developing nations [12].

1. INTRODUCTION
Toxoplasma
gondii
(T.
gondii)
causes
toxoplasmosis, and is an intracellular, obligate,
parasitic protozoan [1]. T. gondii is found
worldwide and is one of the most common
parasites in developed countries, with up to
23.6% in places in Africa [1,2,3]. Healthy adults
may not show any symptoms of infection,
however, individuals having weakened immune
systems the infection can cause serious to fatal
consequences [2]. Epidemiology studies have
shown that up to 84% of individuals in France are
infected [4].
Infection with T. gondii has been shown to be
associated with various neurological disorders,
and in particular schizophrenia [5]. Infection with
T. gondii can occur by eating poorly cooked or
raw meat that contains the T. gondii tissue cysts
[6]. For North America, the greatest threat for
infection comes from raw or poorly cooked pork
[6]. Other modes of infection include blood
transfusions, organ transplant, unpasteurized
goat milk, soil contact, and consumption of
contaminated vegetables/fruits [6]. The Protozoa
group are diverse unicellular eukaryotic
organizms, most of which range in size from 10
micrometers to 52 micrometers [7]. These
organisms
are
abundant
in
aqueous
environments and soil [7]. Other protozoan
diseases associated with humans include
[7]:
Malaria,
Amoebiasis,
Giardiases,
Trichomoniasis, Chagas disease, Leishmaniasis,
Sleeping Sickness, and Amoebic dysentery.

Structure-based drug design is most efficacious
when it is a part of a complete drug lead
discovery process (i.e. new designs for additional
clinical
medicaments).
Substitution
of
substituents of a parent compound (simplest
member of a group of compounds) pursues the
objective of chemical similarity that includes the
generation of isosteres. The entity having
chemical similarity (or molecular similarity), refers
to the similarity of chemical elements with
respect to either structural and/or the biological
effect of the chemical compound [13].
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Hierarchical cluster analysis was performed by
KyPlot v. 2.0 (copyright Koichi Yosioka 1997 to
2001 and K-means cluster analysis was
performed by PAST v. 2.06 (copyright Oyvind
Hammer, D.A.T. Harper 1999-2008).

Computer-aided drug discovery/design methods
have played a major role in the development of
therapeutically important small molecules [13].
Computer-aided drug design has enabled the
focus of drug discovery to achieving the best
potency against a biological target of interest,
and
favorable
absorption,
distribution,
metabolism, and excretion (ADME) [13]. A
heuristic approach employs a practical method
(not necessarily optimal), but sufficient for the
immediate goals. When finding an optimal
solution is impractical, heuristic methods can be
used to speed up the process of finding a
satisfactory solution [13].

2.3 Various Statistical Analysis Data
Methods of statistical analysis applied included
Pearson r correlation and univariate descriptive
statistics were accomplished by Microsoft
EXCEL v. 14.0.6112.5000 (EXCEL Professional
plus 2010). Pearson r correlation was also
determined by using PAST v. 2.06. Multiple
regression by Graph Pad Instat version 3.00
(GraphPad Software, Inc., San Diego, California
USA; www.graphpad.com). Box plots were
generated by PAST v. 2.06. Grubb’s test for
outliers accomplished by Graph Pad Quick Calcs
(http://www.graphpad.com/ quickcalcs/index.cfm)

Clearly, the study and development of additional
drug agents to combat Toxoplasma type
infections is of great importance. This study
presents novel derivatives of pyrimethamine by
heuristic
structure
search
and
isostere
identification.
The
drug
pyrimethamine
possesses substituents on the aromatic ring that
facilitates and makes efficacious the isosteric
substituent of atoms. The compounds that result
are shown to have efficacious molecular
properties when compared to the parent drug
pyrimethamine and by their similarity score.

3. RESULTS AND DISCUSSION
3.1 Structure and Properties
Therefore, the computer-aided heuristic similarity
search accompanied by isostere identification
has revealed 30 new molecular structures for the
treatment of protozoan T. gondii infections. The
chemical structure of pyrimethamine with the six
isostere compounds is presented for comparison
in Fig. 1. The pyrimethamine molecule and six
isosteres have various attributes in common. All
seven compounds have an aromatic ring and a
pyrimidine ring having a primary amine group (or
pyrimidin-2-amine group), with a second primary
amine group and one ethyl substituent (or 6ethylpyrimidine-2, 4-diamine group).

2. METHODOLOGY
2.1 Properties and Molecular Modeling
For all 31 compounds included in this study, the
numerical values of molecular properties were
determined by utilizing heuristic techniques of
Molinspiration (Molinspiration Cheminformatics,
Nova ulica 61, SK-900 26 Slovensky Grob,
Slovak Republic). Similarity search and isostere
elucidation was accomplished by Molinspiration.
Similarity
scoring
and
correlation
to
pyrimethamine
for
all
structures
was
accomplished by Molinspiration. Construction
and presentation of molecular structure was
accomplished by use of ACD ChemSketch
Modeling v. 12.01 (Advanced Chemistry
Development, 110 Yonge Street, Toronto
Ontario, M5C 1T4 Canada) and Molinspiration
(http://www.molinspiration.com/services/search.h
tml)

2.2 Pattern Recognition and Multivariate
Statistical Analysis

The pyrimethamine structure has a 4chlorophenyl group covalently attached to the 6ethylpyrimidine-2,4-diamine framework. The
isosteres are formed upon substitution of the 4chloro atom with analogous atoms (i.e. same
number of atoms and/or the same number of
valence electrons). The selection of the isostere
substitutions were selected to optimize drug
likeness of the new formed compounds and
maintain the attributes of isostere (i.e. maintain
same number of atoms/valence electrons).
Isosteres are known to be effective for enhancing
drug likeness [13,14,15,16].

Identification of underlying associations and
patterns within the numerical values of molecular
properties done by use hierarchical cluster
analysis and K-means cluster analysis.

This accomplished, compound (2) has a
phosphane group (-PH2) substituting for the
chlorine atom of pyrimethamine drug (see Fig. 1).
Following in order, compounds 3, 4, 5, 6,
3
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of drug-likeness and have favorable membrane
permeation and bioavailability [14]. The RO5 was
formulated after examination of over 2000 known
drugs and observing that orally administered
drugs are relatively small and moderately
lipophilic molecules [14]. The RO5 states that if a
compound violates any two of the following
rules, it is likely to exhibit poor intestinal
absorption [14]: 1) Molecular weight greater than
500; 2) Number of hydrogen bond donors more
than 5 (where, a donor being any O-H or
N-H group); 3) Number of hydrogen bond
acceptors more than 10 (where, an acceptor
being any O or N including those in donor
groups); and 5) Calculated Log P greater than
5.0.

and 7 have the following atoms substituting
for the chlorine atom of pyrimethamine,
respectively:
(3) –SH atoms; (4) –F atom; (5) –OH atoms;
(6) –NH2 atoms; and (7) –CH3. The
alterations these substitutions bring about on
the molecular properties are presented in
Table 1 and will be discussed next.
For most drugs, the preferred route of
administration is by oral ingestion [13].
Therefore,
investigators
seek
the
physicochemical properties that favor intestinal
absorption [13,14]. The rule-of-5 (RO5) is a rapid
screen for compounds likely to fit the parameters

Pyrimethamine

CH3

CH3
N

N

1

H2N

5

Cl

H2N

OH
N

N
NH2

NH2

CCc1nc(N)nc(N)c1c2ccc(Cl)cc2

CCc1nc(N)nc(N)c1c2ccc(O)cc2

CH3

CH3

N

2

H2N

6

PH2

N
H2N

N

NH2
N

NH2

NH2

CCc1nc(N)nc(N)c1c2ccc(P)cc2

CCc1nc(N)nc(N)c1c2ccc(N)cc2

CH3

CH3

N

3

N

H2N

7

SH
N

H2N

CH3
N

NH2

NH2

CCc1nc(N)nc(N)c1c2ccc(S)cc2

CCc1nc(N)nc(N)c1c2ccc(C)cc2

CH3
N

4

H2N

F
N
NH2

CCc1nc(N)nc(N)c1c2ccc(F)cc2

Fig. 1. Isosteres (molecules or ions with the same number of atoms and/or the same number of
valence electrons) of pyrimethemine (1)
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Table 1. Molecular properties of compounds
Drug

Log P

1 Pyrimethamine
2 isostere
3 isostere
4 isostere
5 isostere
6 isostere
7 isostere
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31

2.84
2.82
2.39
2.32
1.68
1.23
2.61
2.16
2.85
4.05
3.33
1.48
1.81
3.00
2.51
2.38
1.15
4.05
4.08
2.02
4.28
1.71
1.34
3.77
3.65
3.40
3.45
3.51
1.42
2.55
4.18

Polar surface
area
2
(Angstroms )
77.83
77.83
77.83
77.83
98.06
103.85
77.83
77.83
45.75
17.31
30.20
84.93
54.87
34.38
34.90
34.90
55.12
17.31
34.38
46.09
17.31
45.75
93.62
17.31
17.31
34.38
83.64
17.83
55.12
39.43
17.31

Number
of
atoms
17
17
17
17
17
17
17
16
17
17
17
17
17
17
18
18
18
17
19
18
17
15
16
17
16
18
18
17
19
18
17

Molecular
weight

Number of oxygen
& nitrogen atoms

248.72
246.25
246.34
232.26
230.27
226.29
228.30
214.27
228.29
242.71
264.12
230.27
250.69
222.25
307.19
262.74
244.29
242.71
270.72
241.29
263.13
200.24
213.24
246.68
228.68
236.27
264.67
242.71
258.32
239.28
287.16

4
4
4
4
5
5
4
4
3
2
3
5
4
3
3
3
4
2
3
4
2
3
5
2
2
3
6
2
4
4
2
5

Number of
-OH &
-NHn
4
4
4
4
5
6
4
4
1
0
0
3
1
0
0
0
1
0
0
0
0
1
5
0
0
0
1
0
1
0
0

Violations
of rule of 5
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

Number
of rotatable
bonds
2
2
2
2
2
2
2
2
3
1
1
2
2
2
3
3
3
1
2
4
1
1
0
1
1
2
3
1
4
2
1

Volume
(Angstroms3)
216.62
222.49
220.74
208.01
211.10
214.37
216.64
203.09
221.99
210.75
203.57
211.91
210.67
199.64
240.26
235.91
230.39
210.75
229.74
228.83
207.73
188.39
187.84
199.12
194.19
216.20
212.97
210.75
247.19
218.60
215.10
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Shown in Table 1, for compounds 1 to 7 in
Fig. 1, all seven compounds show favorable
bioavailability and membrane penetration
(favorable drug-likeness) with zero violations of
RO5, with agent 6 showing only one violation of
the RO5. This is a beneficial and favorable
outcome for the efficacy of these six isosteres of
pyrimethamine. In addition, previous studies
have shown that drugs having polar surface area
(PSA) greater than 140 Angstroms2 are poorly
absorbed [13,15]. Note, that all agents 1 to 7
have PSA less than 103.85 Angstroms2 and are
expected to be well-absorbed following ingestion.
Other properties of pyrimethamine have a very
strong negative relationship (Pearson’s r
correlation less than -0.7000) for PSA, number of
–OH, -NHn, oxygen atoms, and nitrogen atoms.
The molecular weight (MW) of pyrimethamine is
a very strong positive correlation to MW of all six
isosteres (Pearson r = 0.7031).

Looking at the whole of Table 1, the molecular
properties, the Grubb’s test for outliers showed
no outliers for all 31 agents in the following
descriptors: Log P, polar surface area, number of
atoms, molecular weight, number of oxygen &
nitrogen atoms, number of –OH and –NHn
groups, number of rotatable bonds, and
molecular volume. This result is a clear indication
that the six isosteres and remaining 24
compounds are extremely consistent in
properties. This and the favorable indicator for
favorable bioavailability supports the contention
that these 30 novel drug designs would have
efficacy of biological activity analogous to
pyrimethamine and potential clinical application.

3.2 Pattern Recognition Identification of
Interrelationships
Structural similarity is one of the basic underlying
principles in drug discovery and development
[16]. The basic underlying principle of compound
subset
selection
and
structure-activity
relationship studies presumes that compounds
which are similar to biologically active molecules
should themselves also be active, and vice versa
[16]. Therefore, determination of similarity is
among the most intensively studied areas with
numerous methods published [16].

The compounds presented in Fig. 2 are derived
from heuristic search for chemical similarity to
pyrimethamine. Compounds 8 through 19
showed a similarity score to pyrimethamine of
0.66 to 0.87. The greater the similarity score, the
higher the correlation to pyrimethamine.
Compounds 8 through 19 have a very broad
variation in molecular scaffolding, however, the
molecular properties are still showing zero
violations of RO5, indicating favorable druglikeness to bioavailability.

In data mining, hierarchical cluster analysis is a
method of cluster analysis that seeks to build a
hierarchy of clusters [17,18]. Cluster Analysis
goals are to relate the grouping a collection of
objects (i.e., observations, individuals, cases, or
data rows) into subsets or clusters, where those
within each cluster are more closely related to
one another than objects assigned to different
clusters [17,18]. Central to cluster analysis is the
concept of degree of similarity (or dissimilarity)
between the individual objects being clustered.
There are two major methods of clustering:
hierarchical clustering and K-means clustering.
Both will be applied to this study.

Compounds 8 to 19 show aromatic rings, heteroatomic aromatic rings, halogen atoms, and
aliphatic substituents. Overall the variation in
structure is broad, however consistency in
molecular properties with the features of
pyrimethamine is clear and paramount.
The compounds presented in Fig. 3 are derived
from heuristic search for chemical similarity to
pyrimethamine. Compounds 20 through 30
showed a similarity score to pyrimethamine of
0.62 to 0.65. The greater the similarity score, the
higher the correlation to pyrimethamine.
Compounds 20 through 31 have a very broad
variation in molecular scaffolding, however, the
molecular properties are still showing zero
violations of RO5, indicating favorable druglikeness to bioavailability.

The Dendrogram presented in Fig. 4 shows the
results of hierarchical cluster analysis of all 31
agents presented in Table 1. Conditions of
cluster analysis are Euclidean distance and
single-linkage clustering (distance between one
cluster and another cluster is equal to the
shortest distance from any member of one
cluster to any member of the other cluster) [17,
18]. The Dendrogram is divisive approach with all
observations starting in one cluster (A), and then
splitting as it moves down the hierarchy.

Compounds 20 to 31 show aromatic rings,
hetero-atomic aromatic rings, halogen atoms,
and aliphatic substituents. Overall the variation in
structure is broad, however consistency in
molecular properties with the features of
pyrimethamine is clear and paramount.
6
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CH3
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N
O
H
O=C2C(Cl)=C(C)NC(=O)N2Cc1ccccc1

O
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Fig. 2. Outcome of heuristic similarity search with compounds having similarity score
0.66 to 0.87
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H3C
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N
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Fig. 3. Outcome of heuristic similarity search for compounds having similarity scores
0.62 to 0.65
In divisive
(compounds)
resolved into
steadily until

cluster analysis, all objects
begin in cluster A, but then are
clusters holding analogous agents
all 31 agents are distinguished.

Leading from node A, agent 6 (isostere) is
determined to be unique from the remaining 30
agents, most likely due to the highest polar
surface area (103.85 Angstroms2). Agent 6, 27,
8
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Cluster 3: 1 (pyrimethamine), 2, 3, 4, 5, 6, 7, 8,
12, 23, and 27.
Cluster 4: 9, 10, 14, 18, 22, 24, 25, 26, 28, and
30.
Cluster 5: 15.

22, and 23 are determined to be distinguished
from all other agents found under node B. Agent
19 is determined to be distinct from all other
agents found under node B, potentially due to a
very high Log P (4.08), but with a low polar
2
surface area (34.38 Angstroms ). Virtually all the
remaining agents are found under node C,
leading to node D containing agents 8, 12, 5, 7,
4, 3, 2, and 1 (pyrimethamine). Ultimately, the
agents most similar to pyrimethamine (agent 1)
are the isosteres 2, 3, 4, and 7. This outcome is
accordant that isostere compounds are
molecules or ions having the same number of
atoms and/or the same number of valence
electrons.

Interestingly, all isosteres found in search engine
are determined to have the highest similarity to
the parent compound pyrimethamine (cluster 3).
This result is consistent with hierarchical cluster
analysis. In addition, agents 8, 12, 23, and 27 are
added to cluster 3. Compound 15 (cluster 5) is
determined to be distinct from all other
compounds. The determination of isosteres of
pyrimethamine shows to be of the highest
similarity among 30 compounds selected
by search engine is consistent for both
approaches to cluster analysis (hierarchical and
K-means).

K-means
cluster
analysis
an
unsupervised algorithm to solve the clustering
goal. The method classifies a data set to a
certain number of clusters determined prior to
analysis [18]. Again, the outcome are a number
of clusters chosen before analysis where each
drug is designated with other drugs that have the
highest similarity [18]. The result of K-means
cluster analysis of agents shown in Table 1 are
following, with isosteres represented in bold:

Box plots or box and whisker diagrams is a
standardized statistical method to visualize the
displaying the distribution of data based on the
five number summary: minimum, first quartile,
median, third quartile, and maximum [18]. Box
and whisker plots are very useful when large
numbers of observations are involved and when
two or more data sets are being compared.
Boxplots display two common measures of the

Cluster 1: 11, 19, 21, and 31.
Cluster 2: 13, 16, 17, 20, and 29.

Fig. 4. Hierarchical cluster analysis of compound molecular properties presented in Table 1.
Analysis utilized standard Euclidean distance with single linkage for clusters. Super-node A,
encompassing all compounds, is divided into clusters of compound (see Table 1) based on
highest similarity. Node B excludes compounds 22, 27, and 6. Node C excludes 15, 16, 17, 20,
29, 19, 23, 22, 27, and 6. Node D includes compounds 1, 2, 3, 4, 7, 5, 12, and 8. Node E includes
compounds 1, 2, 3, 4, and 7

9
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variability or spread in a data set: Range the
spread of all the data; and Interquartile range
(the middle half of a data set falls within the
interquartile range).

hydrogen bond acceptor and hydrogen bond
donor characteristic of the molecule. These
values, shown in the box plots, are highly
consistent for all 31 agents and very small in
range (i.e. having whiskers very close to the
medians).

Observing the box plots for molecular properties
(see Fig. 5), the medians are indicated within the
box with the range by the whiskers [18]. The box
plots show visually the relative position of the
medians and ranges of each molecular property
listed in Table 1. The broadest ranges (maximum
to minimum) are found with polar surface area,
molecular weight, and volume. Their ranges,
respectively, are 17.31 Angsroms2 to 103.85
Angstroms2, 200.24 Dalton to 307.19 Dalton,
3
to
247.19
and
187.84
Angstroms
3
Angstroms .

Utilizing box plots presented in Fig. 5, it is readily
seen that numerical values from minimum to
maximum is small and are extremely close to the
median, upper, and lower quartile (except for
PSA, molecular weight, and molecular volume).
Most of the descriptors of all 30 compounds are
highly consistent, numerically close in proximity,
and very close to the group medians. In addition,
and further evidence the 31 compounds have
very strong positive relationship are results of
Pearson correlation of one compound to another
(applying all properties, see Table 1), are all
greater than 0.9700. Taken together, the box
plots and Pearson r correlation clearly show that
pyrimethamine, isosteres, and similarity search
structures are very highly similar and with
properties indicating clinically favorable druglikeness,
permeability,
and
membrane
penetration.

Interestingly, most molecular properties have a
very small range from minimum to maximum that
are very close to the median. These descriptors
are Log P, number of atoms, number of oxygen
& nitrogen atoms, number of –OH & -NHn
groups, violations of the rule of 5, and number of
rotatable bonds. The oxygen, nitrogen, hydroxyl
(-OH), and amine (-NHn) groups account for the

Fig. 5. Box plots of properties presented in Table 1, with whiskers of one standard deviation
This representation shows numerical dispersion of values and range of numerical values
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only slightly and be statistical analysis are shown
to adhere to rigid analogy to parent drug
pyrimethemine. With the great success of
isostere modification of a successful lead, these
30 agents (2 to 31) have potential to be useful in
the clinical treatment of protozoan diseases.

3.3 Multiple Regression and Prediction
Multiple regression analysis is a powerful
technique for predicting the value of an
dependent variable from the known value of two
or more independent variables, referred to as
predictors [19]. In this analysis, the predictors are
molecular properties such as Log P and polar
surface
area,
having
significance
as
pharmaceutical properties. For compounds 1 to
31, and utilizing the properties given in Table 1,
we can form analysis with Log P, polar surface
area (PSA), number of atoms (nAtoms), number
of oxygen & nitrogen atoms (nON), number of –
OH and –NHn, molecular volume (MV), and
number of rotatable bonds (nRotB):

4. CONCLUSION
Pyrimethamine is an important drug for the
treatment of protozoan infections. Thirty agents
were identified to be analogous to pyrimethamine
following heuristic search engine, six of the
agents as isosteres. The result of search engine
identified 30 agents that were highly consistent in
important pharmacological properties such as
Log P and polar surface area. Grubb’s test for
outliers showed no outlying values for Log P,
polar surface area, molecular weight, and four
other molecular properties. All compounds in this
study showed favorable bioavailability, having
zero violations of the rule of 5. Hierarchical
cluster analysis and K-means cluster analysis
showed that the isostere compounds were most
similar to pyrimethamine. Multiple regression
analysis produced a mathematical model for
predicting properties of compounds of similar
medicinal use. The study and design of new
medicinal agents for treatment of protozoan
infections is a vital endeavor with great demand
in the future.

MW = -85.632 + 11.026(LogP) –
0.1324(PSA) – 9.156(nAtoms) +
14.362(nON) – 5.014(nOHNH) + 5.445 (rule
of 5) – 15.523(nRotB) + 2.107(MV)
(1)
2

The relationship (1) shows an R of 0.7060,
indicating the model accounts for 70.60% of the
variance in MW based on the model. The
dependent variables of greatest significance are
the Log P (P=.02), number of rotatable bonds
(P=.04), and molecular volume (P=.01).
Various techniques disseminated to find better
medicines faster include QSAR (Quantitative
structure–activity relationship), structure based
techniques, homology modelling (generating a
homologous structure to the parent drug), and
high throughput screening [20]. This study has
demonstrated the efficacy of applying isosteres
and similarity search utilizing heuristic search
engine. Isosteres for lead modification has been
shown to be highly successful approach to
modify the activity of a lead drug (pyrimethamine
here) and modify toxicity [21]. Applying isosteres
in drug design has been highly successful, in part
due to the only subtle changes of size, shape,
Log P, and hydrogen bonding [21]. The use of insilico chemistry and molecular modeling has
great momentum and potential [22]. In-silico
methods will continue to have substantial
importance in prediction of novel drugs [22].
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This study has shown that specific isostere
substitution and rational similarity search
produced 30 potential agents for anti-protozoan
usage. The drug pyrimethemine has been shown
to be effective for treatment of protozoa
diseases. The 30 agents presented here have
favorable drug-likeness based on the rule of 5
(i.e. good bioavailability and membrane
permeation [14]). Their properties are modified
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